NUTRITIONAL GROWTH SOLUTIONS LTD — Director's Dealing 2026

Apr 9, 2026

ASX ANNOUNCEMENT | 10 APRIL 2026

==> picture [87 x 51] intentionally omitted <==

CHAIR HOLDINGS – APPENDIX 3Y

Nutritional Growth Solutions Limited ( ASX: NGS ) (" NGS " or " the Company ") advises that the attached Appendix 3Y – Change of Director’s Interest Notice is being lodged outside the timeframe prescribed by ASX Listing Rule 3.19A.

Following his appointment as Chair, announced on 24 March 2026, Andrew Grover, in the interests of good corporate governance and transparency, has chosen to include shares that are exclusively controlled by his spouse, subscribed for before he became a director and issued on 24 December 2025. Mr Grover has no relevant interest as he does not control the voting or disposal of those shares. However, the attached Appendix 3Y is consistent with his disclosure of interests for another listed company on which he is a director and addresses any perceived interest that investors may consider he has in the Company’s shares.

The Board takes its continuous disclosure obligations seriously and acknowledges the importance of strict compliance with Listing Rules 3.19A and 3.19B. This instance does not reflect a systemic issue but was determined in the interest of good corporate governance following Mr Grover’s appointment as Chair.

The Board is satisfied that its governance practices are adequate to meet the Company’s ongoing compliance obligations.

This announcement has been authorised for release by the Board.

For further information, please contact:

Andrew Grover

Chair

andrew@ngsolutions.co

About Nutritional Growth Solutions

Nutritional Growth Solutions is a U.S. based health, nutrition, and wellness company. NGS develops, produces and sells clinically tested nutritional supplement formulas for children following 20 years of medical research into pediatric nutrition. The nutritional supplements market has experienced tremendous growth in recent years, but most attention has been focused on adult users and children under three years of age. The three-to twelve-year-old consumers represent a larger

Nutritional Growth Solutions | ASX: NGS | ARBN: 642 861 774 | www.ngsolutions.co 16885 Via Del Campo Court, Suite 218, San Diego, CA 92127

ASX ANNOUNCEMENT | 10 APRIL 2026

==> picture [87 x 51] intentionally omitted <==

market opportunity, and NGS is highly differentiated from its competitors with clinically tested products and an expanding product portfolio to capture this market opportunity.

https://healthyheights.com | https://ngsolutions.co

• For more information visit: https://ngsolutions.co/investor centre/

Nutritional Growth Solutions | ASX: NGS | ARBN: 642 861 774 | www.ngsolutions.co

16885 Via Del Campo Court, Suite 218, San Diego, CA 92127

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity Nutritional Growth Solutions Ltd ARBN 642 861 774

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Andrew Grover
Date of last notice	18 November 2025

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	This notice details the change in the direct holding of A22 Pty Limited, a company wholly owned and controlled by Robyn Brockhurst, whose spouse is Andrew Grover. Mr Grover has no relevant interest in the shares held by A22 Pty Limited, and this disclosure is made in the interest of good corporate governance.
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.	N/A
Date of change	24 December 2025
No. of securities held prior to change	Nil
Class	Ordinary class shares
Number acquired	20,500,000
Number disposed	Nil

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation	$410,000
No. of securities held after change	20,500,000 ordinary class shares
Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back	Issue of shares pursuant to shareholder approval at the General Meeting held on 23 December 2025.

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	N/A
Nature of interest	N/A
Name of registered holder (if issued securities)	N/A
Date of change	N/A
No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed	N/A
Interest acquired	N/A
Interest disposed	N/A
Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation	N/A
Interest after change	N/A

Part 3 –[+] Closed period

Were the interests in the securities or contracts detailed No above traded during a[+] closed period where prior written clearance was required?

If so, was prior written clearance provided to allow the trade N/A to proceed during this period?

If prior written clearance was provided, on what date was this N/A provided?

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011